HealthyDirect · GrowthFit for a long SIP
Union Midcap Fund
Union Mutual FundEquity Scheme - Mid Cap Fund6.6 years
The Scheme seeks to achieve long term capital appreciation and generate income by investing predominantly in equity and equity related securities of mid cap companies.
- NAV
- 53.40
- 30 Oct 2026
- 1Y
- +0.7%
- Trailing CAGR
- AUM
- ₹1,905.76 Cr
- 30 Sept 2026
- Volatility
- High
- 16.2% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 76% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Pass
6.6 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.08% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -21.3%. Ask whether you can hold through a similar fall.
Vs category
Pass
76% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Pratik Dharmshi · 1.9 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 25.1% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 21%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+0.7%
- 3Y+15.6%
- 5Y+13.8%
- 10Yn/a
- SI+28.2%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+0.2%
- 3Y+7.4%
- 5Y+13.7%
- 10Yn/a
- Since inception
- +28.2%
- Calendar-day CAGR
- Excess 1Y
- +3.3%
- Category median, same plan and option
- 3Y win rate
- +76%
- Windows beating the median
- 3Y percentile
- 65
- Vs comparable share classes
- SIP 3Y XIRR
- +7.4%
- Simulated monthly SIP
- Worst rolling 3Y
- +14.2%
- 882 daily-ending windows
- Median rolling 3Y
- +22.6%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 392 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -21.3%
- Worst peak-to-trough
- Current
- -9.3%
- Below last peak
- Current spell
- 60 days
- Days below latest peak
- Time below peak
- +81%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 9 days
- 112 recovered episodes
- Longest recovery
- 234 days
- Trough to prior peak
23 Sept 2024 – 20 Oct 2025
Trough 28 Feb 2025 · recovered in 234 days
-21.3%
17 Jan 2022 – 7 Sept 2022
Trough 20 Jun 2022 · recovered in 79 days
-19.3%
13 Sept 2022 – 31 May 2023
Trough 28 Mar 2023 · recovered in 64 days
-12.7%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-12.1%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
65
Vs category
71
Consistency
68
Risk-adjusted
89
Drawdown
47
Mean
68
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 76% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 78 holdings · top 10 are 25.1%.
- Top 5
- 14.1%
- Top 10
- 25.1%
- Largest holding
- 3.1%
- Effective holdings
- 60.1
One 97 Communications Ltd
Industrials
3.1%
The Federal Bank Ltd
Financial
3.0%
Multi Commodity Exchange Of India Ltd
Financial
2.9%
Max Financial Services Ltd
Financial
2.6%
Ipca Laboratories Ltd
Healthcare
2.5%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Baroda BNP Paribas Mid Cap Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +0.8%
- 3Y
- +15.3%
- Vol
- 14.5%
- Max DD
- -18.6%
- Sharpe
- 0.70
- 3Y win
- +97%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
Caveat: Lower trailing returns
Edelweiss Mid Cap Fund
Edelweiss Mutual Fund
- 1Y
- -2.0%
- 3Y
- +19.0%
- Vol
- 17.1%
- Max DD
- -39.2%
- Sharpe
- 0.78
- 3Y win
- +100%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
ITI Mid Cap Fund
ITI Mutual Fund
- 1Y
- -1.3%
- 3Y
- +17.7%
- Vol
- 16.4%
- Max DD
- -22.7%
- Sharpe
- 0.67
- 3Y win
- +100%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Axis Midcap Fund
Axis Mutual Fund
- 1Y
- +1.3%
- 3Y
- +16.1%
- Vol
- 14.9%
- Max DD
- -29.4%
- Sharpe
- 0.82
- 3Y win
- +41%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
HDFC Mid Cap Fund
HDFC Mutual Fund
- 1Y
- -3.0%
- 3Y
- +15.6%
- Vol
- 15.6%
- Max DD
- -39.5%
- Sharpe
- 0.86
- 3Y win
- +76%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown